Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

Mecha, M, Torrao, A S, Mestre, L, Carrillo-Salinas, F J, Mechoulam, R, Guaza, C·2012·Cell Death & Disease

Cited by (141)

Items 101–141 of 141

  1. Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
    Mitchell B. Diccianni, Katarzyna Kempińska, Jon A. Gangoti, Alice Lin-Tsing Yu, Linda S. Sorkin · 2020 · PLoS ONE
  2. A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
    Neda Tadayon, Ali Ramazani · 2021 · Journal of the Iranian Chemical Society
  3. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
    Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Lícia C. Silva-Costa, Aline Gazzola Fragnani Valença, Fernanda Crunfli, Antônio Waldo Zuardi, Jaime E. C. Hallak, José A. Crippa, Valéria de Almeida, Daniel Martins‐de‐Souza · 2021 · Frontiers in Molecular Neuroscience
  4. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
    Yasaman Razavi, Fariborz Keyhanfar, Ronak Shabani, Abbas Haghparast, Mehdi Mehdizadeh · 2021 · PubMed Central
  5. Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia
    Giuliana S. Zuccoli, Caroline Brandão‐Teles, Gabriela Maciel Vieira, Felipe V. Gomes, Fernanda Crunfli · 2022 · Advances in experimental medicine and biology
  6. Autism Spectrum Disorder
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  7. The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
    Shahin Jalali · 2013 · International Neuropsychiatric Disease Journal
  8. Roles of Cannabidiol in Reversing Proteinopathies
    Raju Dash, Md. Chayan Ali, Israt Jahan, Yeasmin Akter Munni, Sarmistha Mitra, Md. Abdul Hannan, Binod Timalsina, Diyah Fatimah Oktaviani, Ho Jin Choi, Il Soo Moon · 2020 · Preprints.org
  9. Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain
    Ivona Costăchescu, Maria-Raluca Gogu, Gabriela Dumitriţa Stanciu, Carmen Solcan, Loredana Horodincu, Andrei Szilagyi, Vlad Constantin Crăciun, Daniela Carmen Ababei, Bogdan-Ionel Tamba · 2026 · Frontiers in Pharmacology
  10. Balancing the Neuroprotective Versus Neurotoxic Effects of Cannabis
    Shravanthi Mouli, Sindhu Ramesh, Manoj Govindarajulu, Mohammed Almaghrabi, Ayaka Fujihashi, Rishi M. Nadar, Julia M. Salamat, Jack DeRuiter, Randall C. Clark, Timothy Moore et al. · 2021 · Springer eBooks
  11. Neurobiology of Cannabinoids and Medical Cannabis in Therapeutic Intervention for Multiple Sclerosis
    Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Saneela Tahseen, Shahid Bashir · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  12. THC induced similar physiological effects on HIV transgenic rats and their controls without affecting HIV-induced deficits in effortful motivation
    Sunitha Vemuri, Samantha M. Ayoub, Arpi Minassian, Jared W. Young · 2026 · Journal of Cannabis Research
  13. Cannabidiol selectively attenuates lipotoxic immunometabolic inflammation in human macrophages
    Mayte Rueda-Munguía, Roberto Rodriguez‐Moncayo, Luis Alberto Luévano‐Martínez, Gerardo García‐Rivas, Elena C. Castillo, Omar Lozano · 2026 · Frontiers in Immunology
  14. Cannabidiol safety
    Andrew Charrette, James A. Akingbasote, Najla Guthrie, Corey J. Hilmas · 2021 · Elsevier eBooks
  15. Cannabis (Marijuana) and Cannabinoids
    Roy Upton · 2020 · Elsevier eBooks
  16. Regulación actual del cannabis visto desde los beneficios terapéuticos de los cannabinoides
    Diana C. Riveros, Eliana Andrea Portilla Mogollón · 2021 · Revista La Propiedad Inmaterial
  17. Dementia: Alzheimer’s Disease
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  18. mTOR Signaling and Endoplasmic Reticulum Stress in Mixed Glial Cultures
    William Theodore Schreiber-Stainthorp · 2015 · Trinity College Digital Repository (Trinity College, Hartford CT)
  19. Molecular mechanism of anandamide-induced apoptosis in non-melanoma skin cancer.
    Eman Soliman · 2015 · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
  20. Efeito do agonista seletivo do receptor canabinoide 1 (CB1) em modelos de neurodegeneração induzida pela estreptozotocina.
    Fernanda Crunfli · 2018
  21. EFFECTS OF CANNABIDIOL ON VOCAL LEARNING AND RECOVERY FROM CNS DAMAGE
    Ali Mohammed Alalawi · 2019 · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
  22. Neuroprotective Effects of Cannabidiol Following Concussion: A Case Study
    Jyotpal Singh · 2019 · oURspace (University of Regina)
  23. Mecanismos celulares e neuroquímicos do efeito tipo-antipsicótico do canabidiol: envolvimento dos receptores 5-HT1A e CB2
    Naielly Rodrigues da Silva · 2021
  24. Tumor necrosis factor α, agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunephenotype of stem cells from human exfoliated deciduous teeth
    Marizia Trevizani, Laís Lopardi Leal, João Vitor Paes Rettore, Gilson Costa Macedo, Caio César de Souza Alves, Sandra Bertelli Ribeiro de Castro, Antônio Márcio Resende do Carmo, Silvioney Augusto da Silva, Carlos Magno da Costa Maranduba, Fernando Sá Silva · 2022 · Research Square
  25. Efeitos da suplementação de benfotiamina, um análogo sintético da vitamina B1, sobre o metabolismo energético neuronal e progressão da neurodegeneração em um modelo experimental de doença de Alzheimer.
    Ruan Carlos Macêdo de Moraes · 2020
  26. Proteomic analysis of cannabinoids in human oligodendrocyte cells
    Valéria de Almeida · 2023 · Elsevier eBooks
  27. Participação da NAPE-PLD e de mecanismos de neuroplasticidade do córtex pré-frontal ventromedial nos efeitos antiestresse da combinação de doses subefetivas de canabidiol e escitalopram
    Franciele Franco Scarante · 2023
  28. Newer Modalities in Psychopharmacology in Children and Adolescents: A Selective Narrative Review of the Literature
    Pradeep Rao, Hugo A. E. Morandini · 2023 · Journal of Indian Association for Child and Adolescent Mental Health
  29. "Cannabinoids as Potential Therapeutic Agents for Kidney and Liver Toxicity: A Review"
    Ali Mohammed Alalawi · 2023 · Journal of advanced Biomedical and Pharmaceutical Sciences
  30. Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth
    Marizia Trevizani, Laís Lopardi Leal, João Vitor Paes Rettore, Gilson Costa Macedo, Caio César de Souza Alves, Sandra Bertelli Ribeiro de Castro, Antônio Márcio Resende do Carmo, Silvioney Augusto da Silva, Carlos Magno da Costa Maranduba, Fernando de Sá Silva · 2023 · Einstein (São Paulo)
  31. Efeito de antipsicóticos e canabidiol em cultura de oligodendrócitos tratados com cuprizona
    Ana Caroline Brambilla Falvella · 2020
  32. Indicações do Uso do Canabidiol em Neurologia
    Gustavo Bresciani Rossi, Júlia Ribeiro Ferreira, Isabele Cristina Zwang, Vinicius Abe Dantas, Sophie Hemmi Ferreira, GABRIEL BORGES GONÇALVES, Valentina Melo Terra, Isabela Bekari Souza Walter · 2024 · Brazilian Journal of Implantology and Health Sciences
  33. Modulation of the Cannabinoid System for Neonatal Pain Management
    Brian M. Timmerman, Susanne Brummelte · 2025 · Springer eBooks
  34. Reactive OPCs in CNS Injury: From Functional Diversity to Therapeutic Translation
    Sheng-Nan Wang, Hong Liu, Jiali Li, Yi Yuan, Ziwei Dai, Zhida Lan, Chao Huang, Xiao-lin Wei, Cheng He, Zhi-Da Su et al. · 2026 · Neuroscience Bulletin
  35. Membrane exchangers of inorganic cations at the human blood-brain barrier : focus on lithium transport and TRPVs channels in human brain endothelial cells
    Huilong Luo · 2018 · theses.fr (ABES)
  36. Autismus-Spektrum-Störung
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  37. Demenz: Alzheimerkrankheit
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  38. Antinociceptive interaction of Δ9-tetrahydrocannabinol and cannabidiol in a humanized mouse model of sickle cell disease
    Alex Mabou Tagne, Olufunke Florence Ajeigbe, Heidi C Avalos, Francesca Galvani, Saeed Al Masri, Carolina Mireles, Kalpna Gupta, Daniele Piomelli · 2026 · Journal of Pharmacology and Experimental Therapeutics
  39. Cannabis THC:CBD Composition Affects Oligodendrocyte Progenitor Cell Characteristics Following Acute Cannabis Vapor Inhalation in Adult Male and Female Mice
    Colin J. Murray, Hayley H. A. Thorpe, Hakan Kayır, Emiko Osborne, Sean W. Foster, Sophia M. Loewen, Mika Rogers, Haley A. Vecchiarelli, Jibran Younis Khokhar, Marie‐Ève Tremblay · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  40. BindingDB Entry 50045494: Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
    BindingDB · 2016 · UC San Diego
  41. Papel neuroprotetor do canabidiol em ratos neonatos após transecção do nervo isquiático
    Matheus Moreira Perez · 2013